2Yiduo Hu,Xincheng Lu,Guangbin Luo,Department of Genetics,Case Comprehensive Cancer Center and University Hospitals of Cleveland,Case Western Reserve University,Cleveland,OH 44106,United States Yiduo Hu,Department of Cancer Biology,Dana-Farber Cancer Institute,Boston,MA 02115,United States.Effect of Recql5 deficiency on the intestinal tumor susceptibility of Apc^(min) mice[J].World Journal of Gastroenterology,2010,16(12):1482-1486. 被引量：6
5Neugut AL,Jacobson JS,Suh S,et al.The epidemiology of cancer of the small bowel[J].Cancer Epidemiol Biomarkers Prev,1998,7(3):243-251.
6Overman MJ,Pozadzides J,Kopetz S,et al.Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine[J].Br J Cancer,2010,102(1):144-150.
7Bilimoria KY,Bentrem DJ,Wayne JD,et al.Small bowel cancer in the United States:changes in epidemiology,treatment,and survival over the last 20 years[J].Ann Surg,2009,249(1):63-71.
8Kummar S,Ciesielski TE,Fogarasi MC.Management of small bowel adenocarcinoma[J].Oncology(Williston Park),2002,16(10):1364-1369.
9Chang HK,Yu E,Kim J,et al.Adenocarcinoma of the small intestine:a multi-institutional study of 197 surgically resected cases[J].Hum pathol,2010,41(8):1087-1096.
10Dabaja BS,Suki D,Pro B,et al.Adenocarcinoma of the small bowel:presentation,prognostic factors,and outcome of 217 patients[J].Cancer,2004,101(3):518-526.
